Limei Ju
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
- Polyomavirus and related diseases
- Molecular Biology top 10%
- DNA Repair Mechanisms
- Cancer therapeutics and mechanisms
- Mitochondrial Function and Pathology
- CRISPR and Genetic Engineering
- Genomics and Chromatin Dynamics
Papers in
-
- DNA Repair Mechanisms 9
- Pluripotent Stem Cells Research 3
- Cancer therapeutics and mechanisms 3
- Oncology 5
- Cancer-related Molecular Pathways 2
- PARP inhibition in cancer therapy 2
- Co-authors
- Keith W. Caldecott (8 shared papers)Peter J. McKinnon (4 shared papers)Sherif F. El‐Khamisy (3 shared papers)Stuart L. Rulten (3 shared papers)Sachin Katyal (2 shared papers)Zhihong Zeng (3 shared papers)Isabelle Robert (1 shared paper)Bernardo Reina‐San‐Martin (1 shared paper)
- Journals
- DNA repair (3 papers)Molecular Cell (1 paper)Journal of Cell Science (1 paper)Journal of Biological Chemistry (1 paper)EMBO Reports (1 paper)
- Partner nations
- United KingdomUnited StatesEgypt
In The Last Decade
Limei Ju
16 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 70
- Oncology 519
- Molecular Biology 1.0k
- Toxicology 50
- Physiology 32
- Cancer Research 95
Countries citing papers authored by Limei Ju
This map shows the geographic impact of Limei Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limei Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limei Ju more than expected).
Fields of papers citing papers by Limei Ju
This network shows the impact of papers produced by Limei Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limei Ju. The network helps show where Limei Ju may publish in the future.
Co-authors
The 25 scholars most cited alongside Limei Ju, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 267 | |
| 2 | 2016 | 199 | |
| 3 | 2007 | 178 | |
| 4 | 2004 | 158 | |
| 5 | 2013 | 134 | |
| 6 | 2012 | 89 | |
| 7 | 2009 | 71 | |
| 8 | 2017 | 39 | |
| 9 | 2004 | 27 | |
| 10 | 2015 | 20 | |
| 11 | 2019 | 19 | |
| 12 | 2021 | 13 | |
| 13 | 2015 | 6 | |
| 14 | 2016 | 5 | |
| 15 | 2008 | 4 | |
| 16 | Anticancer drug resistance of HeLa cells transfected with rat glutathione S-transferase pi gene. | 2003 | 2 |
About Limei Ju
Limei Ju is a scholar working on Molecular Biology, Oncology, Developmental Neuroscience, Pharmacology and Cellular and Molecular Neuroscience, having authored 16 papers that have together received 1.2k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (9 papers), Neurogenesis and neuroplasticity mechanisms (3 papers), Pluripotent Stem Cells Research (3 papers), Cancer therapeutics and mechanisms (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Cancer-related Molecular Pathways (2 papers), PARP inhibition in cancer therapy (2 papers) and Advanced Radiotherapy Techniques (1 paper). The work is most often cited by research in Oncology (519 citations), Molecular Biology (1.0k citations), Toxicology (50 citations), Physiology (32 citations) and Cancer Research (95 citations). Limei Ju has collaborated with scholars based in United Kingdom, United States and Egypt. Frequent co-authors include Keith W. Caldecott, Peter J. McKinnon, Sherif F. El‐Khamisy, Stuart L. Rulten, Sachin Katyal, Zhihong Zeng, Isabelle Robert, Bernardo Reina‐San‐Martin, Anna E.O. Fisher and Michèle Rouleau. Their work appears in journals such as DNA repair, Molecular Cell, Journal of Cell Science, Journal of Biological Chemistry and EMBO Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.